Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00504582 · ClinicalTrials.gov registry record · NA
Fibrin Melanoma Axillary Node Study in Patients With Melanoma
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT00504582: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00504582 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 121 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00504582, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
Primary Objective: * To determine whether the use of a fibrin sealant applied to axillary soft tissues following node dissection can result in earlier drain removal. Secondary Objectives: * To determine the postoperative morbidity rate using fibrin sealant following axillary node dissection. * To assess patient-valuation of outcome by performing a cost-benefit analysis using a willingness-to-pay model. * To determine if serum levels, lymphatic fluids level, or cutaneous expression of vascular endothelial growth factor-D (VEGF-D), vascular endothelial growth factor-C (VEGF-C) or their receptor, vascular endothelial growth factor receptor-3 (VEGFR-3) correlates with nodal tumor burden or development of lymphedema in patients with melanoma.
Interventions
- DRUG Fibrin Sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2002-05-15 |
| Est. Completion | 2020-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00504582
The ClinicalTrials.gov registry entry for NCT00504582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fibrin Sealant is the first listed.
NCT00504582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00504582 about?
NCT00504582 is a clinical study titled "Fibrin Melanoma Axillary Node Study in Patients With Melanoma". Primary Objective: * To determine whether the use of a fibrin sealant applied to axillary soft tissues following node dissection can result in earlier drain removal. Secondary Objectives: * To determine the postoperative morbidity rate using fibrin sealant following axillary node dissection. * To...
What is the current status of trial NCT00504582?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2002-05-15. Estimated completion is 2020-04-09.
What interventions are being tested in trial NCT00504582?
The interventions under investigation include: Fibrin Sealant (DRUG).
Who is sponsoring clinical trial NCT00504582?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.